BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives

Reuters2024-12-27

BRIEF-Viracta <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives

Dec 26 (Reuters) - Viracta Therapeutics Inc VIRX.O:

VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVES
VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VAL
VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDING
VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALE

Source text: ID:nGNXbcqMCQ

Further company coverage: VIRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2494182078?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-27 05:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2494182078","market":"us","top_or_hot":-1,"title":"BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Viracta <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives</title></head><body><p><span>Dec 26 (Reuters)</span><span> - </span>Viracta Therapeutics Inc <span>VIRX.O</span>:</p><ul><li><p>VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVES</p></li><li><p>VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VAL</p></li><li><p>VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDING</p></li><li><p>VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALE</p></li></ul><p>Source text: <span>ID:nGNXbcqMCQ</span></p><p>Further company coverage: <span>VIRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-12-27 05:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Viracta <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives</title></head><body><p><span>Dec 26 (Reuters)</span><span> - </span>Viracta Therapeutics Inc <span>VIRX.O</span>:</p><ul><li><p>VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVES</p></li><li><p>VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VAL</p></li><li><p>VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDING</p></li><li><p>VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALE</p></li></ul><p>Source text: <span>ID:nGNXbcqMCQ</span></p><p>Further company coverage: <span>VIRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241226:nTUA4PYJLR:1","article_id":"2494182078","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494182078","pubTimestamp":1735250292,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic AlternativesDec 26 (Reuters) - Viracta Therapeutics Inc VIRX.O:VIRACTA THERAPEUTICS ANNOUNCES CLOSUR","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技"},"translate_title":"简报-Viracta Therapeutics宣布结束Naval-1临床试验并探索战略替代方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIRX":0.9},"content_text":"BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic AlternativesDec 26 (Reuters) - Viracta Therapeutics Inc VIRX.O:VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVESVIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VALVIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDINGVIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALESource text: ID:nGNXbcqMCQFurther company coverage: VIRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2494182078","isCrawlerRequest":true}